# K130987: Valutrode Neurostimlation Electrodes

- Pathway: 510(k) (Traditional)
- Applicant: Axelgaard Mfg. Co., Ltd.
- Decided: Jul 17, 2013 after 99 days
- Product code: GXY (Electrode, Cutaneous)
- Device class: 2
- Regulation: 21 CFR 882.1320
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K945676 (1995). 10 ancestors in all.
10 later devices descend from it; 4 cite it directly.
0 of 21 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K083302: Lifecare Electrodes, Everyway Medical Instruments Co.,Ltd (2009) Summary page 1.
- K970426: Valuetrode, Axelgaard Mfg. Co., Ltd. (1997) Summary page 1.

## Most influential descendants
- K150971: Zekang Self-adhesive Electrode (2015), 5 descendants of its own
- K152648: Ennova Self-adhesive Electrode (2016), 4 descendants of its own
- K182111: DL Self-adhesive Electrode (2019), 3 descendants of its own
- K241512: Electrode Pad (2025), 1 descendant of its own
- K140586: Ascend Electrode (2014), 1 descendant of its own

## Indications for use
ValuTrode® reusable, self-adhering, over-the-counter Neurostimulation Electrodes are indicated for use with transcutaneous electrical stimulation devices. Some common types of transcutaneous stimulation devices include, but are not limited to, transepithelial nerve stimulation (TENS) and electrical muscle stimulation (EMS) devices. Transcutaneous Neurostimulation Electrodes are passive devices serving as an interface between a user's skin and a neurostimulation device.

Source page: https://510kreport.com/device/K130987
Methodology: https://510kreport.com/methodology